Abstract
Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Angioplasty, Balloon, Coronary*
-
Animals
-
Coronary Restenosis / blood*
-
Coronary Restenosis / etiology
-
Coronary Restenosis / prevention & control
-
Humans
-
Hyperplasia / etiology
-
Hyperplasia / metabolism
-
Plasminogen Activator Inhibitor 1 / metabolism*
-
Tunica Intima / pathology
Substances
-
Plasminogen Activator Inhibitor 1